Sana Biotechnology (SANA) Retained Earnings (2020 - 2026)

Sana Biotechnology has reported Retained Earnings for 7 years, with the latest figure at $2.0 billion in Q1 2026.

• Quarterly Retained Earnings changed N/A year-over-year to $2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (changed N/A YoY) and the FY2025 annual result came in at $2.0 billion, up 14355935.71% from the prior year.
• Retained Earnings was little changed at $2.0 billion in Q1 2026 per SANA's latest filing, from $2.0 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $2.0 billion in Q1 2026 and troughed at -$1.8 billion in Q3 2025.
• A 5-year average of $400.2 million and a median of $773.4 million in 2022 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 48923.08% in 2022, then surged 14355935.71% in 2025.
• Over 5 years, Retained Earnings stood at $1.6 billion in 2022, then climbed by 4.31% to $1.6 billion in 2023, then tumbled by 100.0% to $14000.0 in 2024, then soared by 14355935.71% to $2.0 billion in 2025, then increased by 0.28% to $2.0 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $2.0 billion, $2.0 billion, and -$1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.